Landmark CIRCULATE-Japan Study Shows Nateras Signatera™ MRD Test is Predictive of Chemotherapy Benefit in Colorectal Cancer

The oral presentation included an updated analysis from the landmark CIRCULATE-Japan trial analyzing a cohort of colorectal cancer (CRC) patients. More than 3,000 CRC patients are now enrolled in ...